Douglas Kerr

Insider Reports History

Entity
Individual
Location
C/O Generation Bio Co., 301 Binney Street, Suite 401, Cambridge, MA
Signature
/s/ Richard Scalzo, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas Kerr:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Dyne Therapeutics, Inc. Chief Medical Officer Common Stock 47.5K $2.18M $45.81 Sep 3, 2024 Direct
Generation Bio Co. CHIEF MEDICAL OFFICER Common Stock 386K $733K $1.90 Jan 29, 2024 Direct
Generation Bio Co. CHIEF MEDICAL OFFICER Restricted Stock Units 0 $0 $1.91 Jan 29, 2024 Direct
Dyne Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 150K Sep 3, 2024 Direct

Insider Reports Filed by Douglas Kerr

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DYN Dyne Therapeutics, Inc. Sep 3, 2024 2 $0 4 Sep 3, 2024 Chief Medical Officer
DYN Dyne Therapeutics, Inc. Sep 3, 2024 0 $0 3 Sep 3, 2024 Chief Medical Officer
GBIO Generation Bio Co. Jan 29, 2024 3 -$2.8K 4 Jan 31, 2024 CHIEF MEDICAL OFFICER
GBIO Generation Bio Co. Jan 15, 2024 6 -$9.35K 4 Jan 17, 2024 CHIEF MEDICAL OFFICER
GBIO Generation Bio Co. Oct 15, 2023 3 -$7.07K 4 Oct 17, 2023 CHIEF MEDICAL OFFICER
GBIO Generation Bio Co. Jul 15, 2023 3 -$11.1K 4 Jul 18, 2023 CHIEF MEDICAL OFFICER
GBIO Generation Bio Co. Apr 15, 2023 3 -$9.82K 4 Apr 18, 2023 CHIEF MEDICAL OFFICER
GBIO Generation Bio Co. Jan 20, 2023 2 $0 4 Jan 24, 2023 CHIEF MEDICAL OFFICER
GBIO Generation Bio Co. Jan 15, 2023 3 -$13.1K 4 Jan 18, 2023 CHIEF MEDICAL OFFICER
GBIO Generation Bio Co. Oct 15, 2022 3 -$12.3K 4 Oct 18, 2022 CHIEF MEDICAL OFFICER
GBIO Generation Bio Co. Jul 15, 2022 3 -$31.4K 4 Jul 19, 2022 CHIEF MEDICAL OFFICER
GBIO Generation Bio Co. Jan 21, 2022 2 $0 4 Jan 25, 2022 CHIEF MEDICAL OFFICER
GBIO Generation Bio Co. Jul 8, 2021 4 -$70.5K 4 Jul 12, 2021 CHIEF MEDICAL OFFICER